S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
pixel
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
North Macedonia gets first batch of Russia vaccine Sputnik V
pixel
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
Asia shares mostly lower on selling of tech stocks
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
pixel
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
North Macedonia gets first batch of Russia vaccine Sputnik V
pixel
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
Asia shares mostly lower on selling of tech stocks
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
pixel
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
North Macedonia gets first batch of Russia vaccine Sputnik V
pixel
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
Asia shares mostly lower on selling of tech stocks
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
pixel
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
North Macedonia gets first batch of Russia vaccine Sputnik V
pixel
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
Asia shares mostly lower on selling of tech stocks
Log in
NASDAQ:NVCR

NovoCure Earnings Date, Estimates & History

$129.28
-3.97 (-2.98 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$117.49
Now: $129.28▼
$134.21
50-Day Range
$133.25
MA: $170.60▼
$190.17
52-Week Range
$53.40
Now: $129.28▼
$194.75
Volume1.21 million shs
Average Volume743,556 shs
Market Capitalization$13.24 billion
P/E Ratio680.46
Dividend YieldN/A
Beta1.29

Earnings

NovoCure (NASDAQ:NVCR) Earnings Information

NovoCure last posted its quarterly earnings data on February 25th, 2021. The medical equipment provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.09. The business earned $144 million during the quarter, compared to analyst estimates of $143.49 million. Its revenue was up 45.2% on a year-over-year basis. NovoCure has generated ($0.07) earnings per share over the last year and currently has a price-to-earnings ratio of 680.5. NovoCure has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 29th, 2021 based off prior year's report dates.

NovoCure Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NovoCure (NASDAQ:NVCR) Earnings Estimates

2021 EPS Consensus Estimate: $0.48
2022 EPS Consensus Estimate: $0.88
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20213$0.06$0.10$0.08
Q2 20213$0.08$0.11$0.10
Q3 20212$0.13$0.14$0.14
Q4 20212$0.15$0.18$0.17
Q1 20221$0.17$0.17$0.17
Q2 20221$0.20$0.20$0.20
Q3 20221$0.23$0.23$0.23
Q4 20221$0.28$0.28$0.28

NovoCure (NASDAQ NVCR) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
4/29/2021
(Estimated)		       
2/25/202112/31/2020$0.13$0.04$0.04$143.49 million$144.00 millionTranscript
10/29/20209/30/2020$0.04$0.09$0.09$120.02 million$132.70 millionTranscript
7/30/20206/30/2020$0.01$0.02$0.02$105.96 million$115.90 millionTranscript
4/30/20203/31/2020$0.03$0.04$0.04$102.10 million$101.83 millionTranscript
2/27/202012/31/2019$0.02$0.04$0.04$99.10 million$99.23 millionTranscript
10/31/2019Q3($0.05)$0.02$0.02$87.12 million$92.06 millionTranscript
7/25/2019Q2($0.07)($0.01)($0.01)$78.98 million$86.70 millionListen
5/2/20193/31/2019($0.13)($0.13)($0.13)$72.85 million$73.31 millionN/A
2/28/2019Q4 2018($0.15)($0.17)($0.17)$69.67 millionN/A
10/25/20189/30/2018($0.15)($0.13)($0.13)$65.61 million$64.76 millionN/A
7/26/2018Q2($0.16)($0.17)($0.17)$59.53 million$61.50 millionN/A
4/26/20183/31/2018($0.13)($0.23)($0.23)$57.13 million$52.13 millionN/A
2/22/2018Before Market($0.14)($0.12)($0.12)$53.17 million$53.66 millionTranscript
10/26/20179/30/2017($0.20)($0.13)($0.13)$43.45 million$50.10 millionN/A
7/27/20176/30/2017($0.23)($0.24)($0.24)$42.20 million$38.38 millionN/A
4/27/20173/31/2017($0.25)($0.21)($0.21)$39.46 million$34.88 millionN/A
2/23/2017Q416($0.39)($0.26)($0.26)$26.95 million$30.20 millionN/A
11/2/2016Q3 2016($0.42)($0.39)($0.39)$21.65 million$21.67 millionN/A
7/28/2016Q216($0.37)($0.48)($0.48)$15.90 million$17.90 millionListen
5/9/2016Q116($0.33)($0.42)($0.42)$23.65 million$13.10 millionN/A
2/29/2016Q4 2015($0.32)$2.54$2.54$17.85 million$12.38 millionN/A
10/26/2015Q315($2.09)($2.09)$4.37 million$8.95 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/8/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.